 - Confirmed evidence of relapsedisease progression from immediately prior MM therapy or refractory to the immediately prior treatment. Refractory disease is defined as those who are non-responsive minimal response on active therapy or experience disease progression within 60 days after the discontinuation of therapy. Relapsed disease is defined as achievement of at least a minimal response followed by disease progression on therapy or within 60 days of discontinuing active therapy. 